These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21798143)

  • 1. Hypertensive encephalopathy: a rare presentation of Williams-Beuren Syndrome.
    Sabir MS; Ali Khan MA; Hasan N
    J Coll Physicians Surg Pak; 2011 Aug; 21(8):509-10. PubMed ID: 21798143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertensive encephalopathy with predominant brain stem involvement: MRI findings.
    Karampekios SK; Contopoulou E; Basta M; Tzagournissakis M; Gourtsoyiannis N
    J Hum Hypertens; 2004 Feb; 18(2):133-4. PubMed ID: 14730329
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe left main coronary artery stenosis with abnormal branching pattern in a patient with mild supravalvar aortic stenosis and Williams-Beuren syndrome.
    Pieles GE; Ofoe V; Morgan GJ
    Congenit Heart Dis; 2014; 9(3):E85-9. PubMed ID: 23701710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of converting enzyme inhibitors, calcium channel blockers and diuretics.
    Sinaiko AR
    J Hum Hypertens; 1994 May; 8(5):389-94. PubMed ID: 8064788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and management of arterial hypertension in children with Williams-Beuren syndrome.
    Bouchireb K; Boyer O; Bonnet D; Brunelle F; Decramer S; Landthaler G; Liutkus A; Niaudet P; Salomon R
    Nephrol Dial Transplant; 2010 Feb; 25(2):434-8. PubMed ID: 19815602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent achalasia in a child with Williams-Beuren syndrome.
    Pereza N; Barbarić I; Ostojić S; Cace N; Kapović M
    Coll Antropol; 2011 Sep; 35(3):941-4. PubMed ID: 22053584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T; Kanno Y; Hayashi K; Konishi K
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
    Ohnishi K; Kohno M; Yukiiri K; Masugata H; Wada Y; Takagi Y; Ohmori K
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):417-22. PubMed ID: 11680666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of blood pressure to maximum exercise in hypertensive patients under different therapeutic programs.
    de Queiroz Carreira MA; Ribeiro JC; Caldas JA; Tavares LR; Nani E
    Arq Bras Cardiol; 2000 Oct; 75(4):281-8. PubMed ID: 11058925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI findings in acute hypertensive encephalopathy.
    Schilling S; Härtel C; Gehl HB; Sperner J
    Eur J Neurol; 2003 May; 10(3):329-30. PubMed ID: 12752413
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker.
    Saleh FH; Jurjus AR
    J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emergency checklist in hypertensive crisis].
    Füessl HS
    MMW Fortschr Med; 2006 Jun; 148(25):49. PubMed ID: 16859163
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intervention studies on elderly hypertensive patients in Japan].
    Saito F; Takahashi A; Kushiro T
    Nihon Rinsho; 2005 Jun; 63(6):1078-85. PubMed ID: 15948394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An infant with Williams-Beuren syndrome and Ebstein anomaly.
    Williams DA; Cook AL
    Cardiol Young; 2010 Aug; 20(4):445-7. PubMed ID: 20465859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
    Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
    Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertensive patients have to be doubly treated earlier. Which antihypertensive drug combination is appropriate to whom?].
    MMW Fortschr Med; 2003 May; 145(22):56. PubMed ID: 12866285
    [No Abstract]   [Full Text] [Related]  

  • 20. Presenting phenotype and clinical evaluation in a cohort of 22 Williams-Beuren syndrome patients.
    Ferrero GB; Biamino E; Sorasio L; Banaudi E; Peruzzi L; Forzano S; di Cantogno LV; Silengo MC
    Eur J Med Genet; 2007; 50(5):327-37. PubMed ID: 17625998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.